| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.06 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |